A Multicenter, Randomized, Controlled Trial of Prednisone Combined With Ursodeoxycholic Acid in the Treatment of Primary Biliary Cholangitis With Moderate to Severe Interface Hepatitis Characteristics

NCT06591468 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

ENROLLING_BY_INVITATION

Status

244

Enrollment

OTHER

Sponsor class

Conditions

Primary Biliary Cholangitis (PBC)

Interventions

DRUG: Prednisone
DRUG: UDCA (Ursodeoxycholic acid)

Sponsor

Han Ying